Histopathology in the Diagnosis and Classification of Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Myelodysplastic/Myeloproliferative Diseases

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pathobiology (Basel)

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000101709PMID 17587881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.

  2009cited by this paper
• Illustrated Pathology of the Bone Marrow

  2007cited by this paper
• Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes

  2006cited by this paper
• Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology

  2006cited by this paper
• Pediatric myelodysplastic syndromes

  2005cited by this paper
• Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia

  2005cited by this paper
• Acute Myeloid Leukemia and Myelodysplastic Syndrome : A Clinical and Morphologic Study of 65 Cases

  2005cited by this paper
• Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults

  2005cited by this paper
• Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining

  2004cited by this paper
• Pediatric myelodysplastic syndromes.

  2004cited by this paper
• Angiogenesis in acute and chronic lymphocytic leukemia.

  2004cited by this paper
• Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

  2004cited by this paper
• Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up

  2004cited by this paper
• Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.

  2003cited by this paper
• Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.

  2003cited by this paper
• International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report

  2002cited by this paper
• Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta

  2002influential reference
• Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.

  2002cited by this paper
• Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.

  2002cited by this paper
• Acute myeloid leukaemia with multilineage dysplasia. .

  2001cited by this paper
• Expression of CD34 by megakaryocytes in myelodysplastic syndromes.

  2000cited by this paper
• Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

  2000cited by this paper
• Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

  2000cited by this paper
• Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.

  2000cited by this paper
• CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameterfor the diagnosis and classification of myelodysplastic syndromes

  2000cited by this paper
• Angiogenesis in myelodysplastic syndromes

  1999cited by this paper
• Biologic characteristics of patients with hypocellular myelodysplastic syndromes.

  1999cited by this paper
• The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes.

  1998cited by this paper
• Problems in the classification of CMML--dysplastic versus proliferative type.

  1998cited by this paper
• Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.

  1997cited by this paper
• Atypical chronic myeloid leukemias.

  1997cited by this paper
• p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.

  1996cited by this paper
• De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.

  1996cited by this paper
• CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia.

  1995cited by this paper
• Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.

  1995cited by this paper
• Hypocellular myelodysplastic syndromes (MDS): new proposals

  1995cited by this paper
• The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group

  1994cited by this paper
• CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes

  1994cited by this paper
• Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.

  1993cited by this paper
• Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.

  1993cited by this paper
• Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.

  1993cited by this paper
• Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.

  1993cited by this paper
• Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?

  1993cited by this paper
• Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors

  1993cited by this paper
• Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis

  1993cited by this paper
• Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

  1993cited by this paper
• A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.

  1993cited by this paper
• Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors

  1993cited by this paper
• The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children

  1992cited by this paper
• The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children.

  1992cited by this paper
• Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.

  1992cited by this paper
• Philadelphia-negative (Ph-) chronic myeloid leukemia (CML) : comparison with Ph+ CML and chronic myelomonocytic leukemia

  1991cited by this paper
• Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity

  1991cited by this paper
• Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.

  1991cited by this paper
• Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.

  1991cited by this paper
• Chronic myelomonocytic leukemia.

  1990cited by this paper
• Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases

  1989cited by this paper
• Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.

  1988cited by this paper
• [Bone marrow histology in myelodysplastic syndromes].

  1987cited by this paper
• The histological characterization of ALIP in the myelodysplastic syndromes.

  1986cited by this paper
• Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases.

  1985cited by this paper
• Bone marrow histology in myelodysplastic syndromes

  1984cited by this paper
• Erythroblastic transformation in myeloproliferative disorders. Confirmation by an immunohistologic technique

  1980cited by this paper
• The Reticulin Content of Bone Marrow in Acute Leukaemia in Adults

  1979cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Atypical chronic myeloid leukaemia.

  1958cited by this paper

• Pediatric myelodysplastic syndrome

  2026cites this paper
• Atypical orbital mass as the precursor for myelodysplastic syndrome recurrence: a case report

  2025cites this paper
• Research advances in the adjunctive diagnosis of acute myeloid leukemia

  2025cites this paper
• Molecular Genetic Analysis of Bone Marrow Core Biopsy as an Alternative or Adjunct to Bone Marrow Aspirate and/or Peripheral Blood in Hematologic Myeloid Neoplasms

  2025cites this paper
• Can polycythaemia vera disease be predicted from haematologic parameters? A machine learning-based study

  2025cites this paper
• MicroRNA dysregulation and its impact on apoptosis-related signaling pathways in myelodysplastic syndrome.

  2024cites this paper
• Myelodysplastic/Myeloproliferative Neoplasms with Features Intermediate between Primary Myelofibrosis and Chronic Myelomonocytic Leukemia: Case Series and Review of the Entity

  2024cites this paper
• Elements in trace amount with a significant role in human physiology: a tumor pathophysiological and diagnostic aspects

  2024cites this paper
• A Short Retrospective Cytometric Note on Myeloblasts in Patients Suffering from Acute Myeloblastic Leukaemia, Myelodysplastic Syndrome and Chronic Myelocytic Leukaemia: Myeloblasts with a Narrow Cytoplasm without Azurophilic Granules Are Less Differentiated Committed Progenitor Stem Cells.

  2024cites this paper
• The Impact of Microenvironment and Dysplasia Types on the Prognosis of Myelodysplastic Syndrome

  2024cites this paper
• Outcome of Post Induction Therapy for Acute Myeloid Leukemia in Nanakaly Hospital-Erbil

  2023influential citation
• Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?

  2023cites this paper
• What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias

  2023cites this paper
• Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review

  2023cites this paper
• CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature

  2023cites this paper
• Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and Management.

  2022cites this paper
• Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world

  2022cites this paper
• How I Diagnose Primary Myelofibrosis.

  2022cites this paper
• Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia

  2022cites this paper
• Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia

  2021cites this paper
• Acute Myeloid Leukemia

  2021cites this paper
• MR Imaging Findings in Serous Atrophy of the Bone Marrow : A Case Study

  2021cites this paper
• Evaluation of related flow cytometry parameters with FAB subtype of acute myeloid leukemia associated with histological assessment

  2021cites this paper
• CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia

  2021cites this paper
• Morphological, fractal, and textural features for the blood cell classification: the case of acute myeloid leukemia

  2021cites this paper
• Accurate Machine-Learning-Based classification of Leukemia from Blood Smear Images.

  2021cites this paper
• Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates

  2021cites this paper
• Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats

  2021cites this paper
• Outcome of acute myeloid leukaemia in Nigeria: clinician’s perspective

  2021cites this paper
• Histopathology of laboratory-reared Nothobranchius fishes: Mycobacterial infections versus neoplastic lesions.

  2021cites this paper
• Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.

  2021cites this paper
• DNA methylation markers in the diagnosis and prognosis of common leukemias

  2020cites this paper
• The power and potential of integrated diagnostics in acute myeloid leukaemia

  2019cites this paper
• Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia

  2019cites this paper
• Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia

  2018influential citation
• The histopathology of bone marrow failure in children.

  2018cites this paper
• A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the “MDS thermometer”

  2018cites this paper
• Histopathology in the diagnosis of high-risk myelodysplastic syndromes.

  2018cites this paper
• Evaluation of the CD 123 Expression and FLT 3 Gene Mutations in Patients with Acute Myeloid Leukemia

  2018influential citation
• Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.

  2018cites this paper
• The Molecular Anatomy of Myelodysplastic Syndromes: An Update

  2018cites this paper
• Current status and trends in the diagnostics of AML and MDS.

  2018cites this paper
• Diagnostics and Prognostication of Myelodysplastic Syndromes

  2017cites this paper
• Rare Bone Marrow Failure Conditions

  2017cites this paper
• A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry

  2017cites this paper
• Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics

  2017cites this paper
• Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome

  2017cites this paper
• Myeloid progenitor cluster formation drives emergency and leukemic myelopoiesis

  2017cites this paper
• Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.

  2017cites this paper
• Expressão gênica de metaloproteinases e de seus reguladores em neoplasias mieloproliferativas: associação com biomarcadores de angiogênese e status mutacional

  2016cites this paper
• Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis

  2016cites this paper
• Diagnosis and Classification of Acute Leukemia in Bone Marrow Trephine Biopsies, Utility of a Selected Panel of Minimal Immunohistochemical Markers

  2016cites this paper
• DNA甲基化对白血病ABO基因表达的影响

  2016cites this paper
• Acute Leukemias of Granulocytic, Erythroid, and Megakaryocytic Lineages

  2016cites this paper
• Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis

  2016cites this paper
• GATA1 mutation negative acute megakaryoblastic leukemia with acquired trisomy 21 presenting with extensive bone marrow necrosis in an adult: A case report and review of the literature

  2016cites this paper
• STUDY OF THE EXPRESSION LEVELS OF SURVIVIN GENE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

  2016cites this paper
• 寛解導入療法のみで長期寛解を維持しているOTT-MAL (RBM15-MKL1) 陽性急性巨核芽球性白血病の乳児例

  2015cites this paper
• GI Bleed with Pancytopenia - A Rare Case of AML Subtype Acute Panmyelosis with Mylefibrosis (APMF)

  2015cites this paper
• Langerhans Cell Histiocytosis and Myelodysplastic Syndrome: A Casual Association or a Pathogenetic Correlation?

  2015cites this paper
• ICSH guidelines for the standardization of bone marrow immunohistochemistry

  2015cites this paper
• Hematopoietic and lymphoid tumors

  2014cites this paper
• Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs

  2014cites this paper
• Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma

  2014cites this paper
• [Algorithm for examination of bone marrow trephine biopsy specimens in myelodysplastic syndromes].

  2014cites this paper
• Detection of RBM 15-MKL 1 Fusion Was Useful for Diagnosis and Monitoring of Minimal Residual Disease in Infant Acute Megakaryoblastic Leukemia

  2014cites this paper
• Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.

  2014cites this paper
• Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis

  2014cites this paper
• The differential diagnosis and bone marrow evaluation of new-onset pancytopenia.

  2013cites this paper
• Comparative Evaluation of Bone Marrow Aspirate with Trephine Biopsy in Hematological Disorders and Determination of Optimum Trephine Length in Lymphoma Infiltration

  2013cites this paper
• Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis

  2013cites this paper
• Differential diagnosis of myelofibrosis based on WHO 2008 criteria: Acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis

  2013cites this paper
• Classification of the Acute Leukemias: Cytochemical and Morphologic Considerations

  2013cites this paper
• Histopathological and immunohistochemical evaluation of bone marrow biopsy in myelodysplastic syndromes

  2013cites this paper
• 17 – Acute Myeloid Leukemia—Overview

  2013cites this paper
• TP53 mutations in myelodysplastic syndromes with deletion of 5q

  2013cites this paper
• Application of immunohistochemistry in the diagnosis and classification of acute leukemia

  2013cites this paper
• Bone Marrow Spectrum of Acute Leukaemia’s at a Tertiary Care Hospital- An Experience

  2013cites this paper
• Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia.

  2012cites this paper
• Megakaryoblastic leukemia presenting as pancytopenia and extensive myelofibrosis in a child diagnosed by myeloid markers and CD 31

  2012cites this paper
• World Health Organization classification of myelodysplastic syndromes.

  2012cites this paper
• CD123 Immunohistochemical Expression in Acute Myeloid Leukemia is Associated With Underlying FLT3-ITD and NPM1 Mutations

  2012cites this paper
• Low blood counts: immune mediated, idiopathic, or myelodysplasia.

  2012cites this paper
• Role of bone marrow imprints in haematological diagnosis: a detailed study of 3781 cases

  2012cites this paper
• Diagnosis and management of neonatal leukaemia.

  2012cites this paper
• CD34+ megakaryocytes (≥30%) are associated with megaloblastic anaemia and non‐acute myeloid neoplasia

  2012cites this paper
• Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis

  2011cites this paper
• Myelodysplastic syndromes.

  2011cites this paper
• La biopsie médullaire dans les syndromes myélodysplasiques

  2011cites this paper
• Myelodysplastic/myeloproliferative neoplasms.

  2011cites this paper
• Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis.

  2011cites this paper
• Significance of Bone Marrow Histology in the Diagnosis of Acute Myeloid Leukemia

  2011cites this paper
• Immunohistochemistry on Epoxy Resin-embedded Bone Marrow Biopsy Experience With 936 Cases

  2011cites this paper
• Acute megakaryoblastic leukemia with a four‐way variant translocation originating the RBM15–MKL1 fusion gene

  2011cites this paper
• Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.

  2011cites this paper
• Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)

  2010influential citation
• Neoplasias mieloproliferativas: revisão dos critérios diagnósticos e dos aspectos clínicos

  2010cites this paper
• Diagnostic Assessment of Bone Marrow Aspiration Smears, Touch Imprints and Trephine Biopsy in Haematological Disorders

  2010cites this paper
• Monoblastic leukaemia/sarcoma of the skin with an indeterminate cell immunophenotype: cyto‐haematological correlation

  2010cites this paper
• Special Stains Use in Fungal Infections

  2010cites this paper